Literature DB >> 20419836

MRI-determined fat content of human liver, pancreas and kidney.

Paul E Sijens1, Mireille A Edens, Stephan J L Bakker, Ronald P Stolk.   

Abstract

AIM: To assess and correlate the lipid content of various organs in obese subjects and in persons with a normal body weight.
METHODS: Magnetic resonance spectroscopy and a previously validated gradient echo magnetic resonance imaging method with Dixon's two point technique were used in this study to quantify fat in liver, pancreas as well as kidney.
RESULTS: In 36 volunteers with body mass index (BMI) ranging from 20.0 to 42.9 kg/m(2), the median fat content of liver, pancreas and kidney was 2.3% (interquartile range: 0.2%-7.8%), 2.7% (1.0%-6.5%) and 0.7% (0.1%-1.4%), respectively. BMI and subcutaneous fat correlated significantly with liver and pancreas fat content. We show for the first time the significant correlation of liver and pancreas fat content in healthy controls (r = 0.43, P < 0.01). These observations are related to body weight as measured by BMI and the amount of subcutaneous fat. Kidney fat content is very low and correlates with none of the other fat depots.
CONCLUSION: Renal lipid accumulation, unlike the coupled accumulations of fat in liver and pancreas, is not observed in obese subjects. Unlike suggestions made in previous studies, renal lipid accumulation appears not to be involved in the pathogenesis of renal disease in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419836      PMCID: PMC2860076          DOI: 10.3748/wjg.v16.i16.1993

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

Review 1.  What aspects of body fat are particularly hazardous and how do we measure them?

Authors:  M B Snijder; R M van Dam; M Visser; J C Seidell
Journal:  Int J Epidemiol       Date:  2005-12-08       Impact factor: 7.196

2.  Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience.

Authors:  Hero K Hussain; Thomas L Chenevert; Frank J Londy; Vikas Gulani; Scott D Swanson; Barbara J McKenna; Henry D Appelman; Saroja Adusumilli; Joel K Greenson; Hari S Conjeevaram
Journal:  Radiology       Date:  2005-10-19       Impact factor: 11.105

3.  Simple proton spectroscopic imaging.

Authors:  W T Dixon
Journal:  Radiology       Date:  1984-10       Impact factor: 11.105

4.  Quantification of liver fat using magnetic resonance spectroscopy.

Authors:  C Thomsen; U Becker; K Winkler; P Christoffersen; M Jensen; O Henriksen
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

5.  Obesity and fat quantification in lean tissues using three-point Dixon MR imaging.

Authors:  Arzu Kovanlikaya; Steven D Mittelman; Andrette Ward; Mitchell E Geffner; Frederick Dorey; Vicente Gilsanz
Journal:  Pediatr Radiol       Date:  2005-03-23

6.  Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.

Authors:  Mark H Fishbein; Chris Mogren; Theodore Gleason; W Ross Stevens
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-01       Impact factor: 2.839

Review 7.  Renal tubule albumin transport.

Authors:  Michael Gekle
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

8.  Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography.

Authors:  R Longo; C Ricci; F Masutti; R Vidimari; L S Crocé; L Bercich; C Tiribelli; L Dalla Palma
Journal:  Invest Radiol       Date:  1993-04       Impact factor: 6.016

9.  Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.

Authors:  Jeanne M Clark; Anna Mae Diehl
Journal:  JAMA       Date:  2003-06-11       Impact factor: 56.272

10.  Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy.

Authors:  Mireille A Edens; Peter M A van Ooijen; Wendy J Post; Mark J F Haagmans; Wisnumurti Kristanto; Paul E Sijens; Erik J van der Jagt; Ronald P Stolk
Journal:  Obesity (Silver Spring)       Date:  2009-05-21       Impact factor: 5.002

View more
  32 in total

1.  Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter].

Authors:  Paul Begovatz; Alessandra Bierwagen; Jesper Lundbom; Michael Roden
Journal:  Diabetologia       Date:  2015-09-23       Impact factor: 10.122

2.  Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus.

Authors:  Manoj Kumar Sarma; Andres Saucedo; Christine Hema Darwin; Ely Richard Felker; Kavya Umachandran; Daniel Kohanghadosh; Edward Xu; Steve Raman; Michael Albert Thomas
Journal:  Magn Reson Imaging       Date:  2020-07-12       Impact factor: 2.546

3.  Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model.

Authors:  Xiaoming Yin; Yang Guo; Weiguo Li; Eugene Huo; Zhuoli Zhang; Jodi Nicolai; Robert A Kleps; Diego Hernando; Aggelos K Katsaggelos; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

4.  Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans.

Authors:  Paul Begovatz; Chrysi Koliaki; Katharina Weber; Klaus Strassburger; Bettina Nowotny; Peter Nowotny; Karsten Müssig; Jürgen Bunke; Giovanni Pacini; Julia Szendrödi; Michael Roden
Journal:  Diabetologia       Date:  2015-03-05       Impact factor: 10.122

Review 5.  Magnetic resonance imaging of pediatric muscular disorders: recent advances and clinical applications.

Authors:  Hee Kyung Kim; Diana M Lindquist; Suraj D Serai; Yogesh K Mariappan; Lily L Wang; Arnold C Merrow; Kiaran P McGee; Richard L Ehman; Tal Laor
Journal:  Radiol Clin North Am       Date:  2013-07       Impact factor: 2.303

6.  Cellular and Molecular Probing of Intact Human Organs.

Authors:  Shan Zhao; Mihail Ivilinov Todorov; Ruiyao Cai; Rami Ai -Maskari; Hanno Steinke; Elisabeth Kemter; Hongcheng Mai; Zhouyi Rong; Martin Warmer; Karen Stanic; Oliver Schoppe; Johannes Christian Paetzold; Benno Gesierich; Milagros N Wong; Tobias B Huber; Marco Duering; Oliver Thomas Bruns; Bjoern Menze; Jan Lipfert; Victor G Puelles; Eckhard Wolf; Ingo Bechmann; Ali Ertürk
Journal:  Cell       Date:  2020-02-13       Impact factor: 41.582

7.  Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.

Authors:  N S Patel; M R Peterson; D A Brenner; E Heba; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2013-02-05       Impact factor: 8.171

8.  Hypertension, but not body mass index, is predictive of increased pancreatic lipid content and islet dysfunction.

Authors:  Daniel M Tremmel; Austin K Feeney; Samantha A Mitchell; Peter J Chlebeck; Sierra A Raglin; Luis A Fernandez; Jon S Odorico; Sara D Sackett
Journal:  Am J Transplant       Date:  2019-12-16       Impact factor: 8.086

9.  Quantification of renal steatosis in type II diabetes mellitus using dixon-based MRI.

Authors:  Takeshi Yokoo; Haley R Clark; Ivan Pedrosa; Qing Yuan; Ivan Dimitrov; Yue Zhang; Ildiko Lingvay; Muhammad S Beg; I Alexandru Bobulescu
Journal:  J Magn Reson Imaging       Date:  2016-03-23       Impact factor: 4.813

10.  Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with (1)H MRS.

Authors:  Roshan S Livingstone; Paul Begovatz; Sabine Kahl; Bettina Nowotny; Klaus Strassburger; Guido Giani; Jürgen Bunke; Michael Roden; Jong-Hee Hwang
Journal:  MAGMA       Date:  2013-12-04       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.